ArticleCancer gene therapy2025

Targeting MTPN sensitizes pancreatic cancer of wild-type BRCA1/2 to Cisplatin-based chemotherapy.

Zhuoxin Wang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.